Coronavirus Vaccine
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 8 of these applications claim priority to application PCT/EP2021/052455, filed Feb 3, 2021. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Patent lifetimeUsedRemaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,241,493 | Coronavirus Vaccine In force · High confidence UsedRemaining | Curevac SE | In force | High confidence | ||
| US 11,471,525 | Coronavirus Vaccine In force · High confidence | Curevac SE | In force | High confidence | ||
| US 11,576,966 | Coronavirus Vaccine In force · High confidence | Curevac SE | In force | High confidence | ||
| US 11,596,686 | Coronavirus Vaccine In force · High confidence | Curevac SE | In force | High confidence | ||
| US 11,964,011 | Coronavirus Vaccine In force · High confidence | Curevac SE | In force | High confidence | ||
| US 11,964,012 | Coronavirus Vaccine In force · High confidence | Curevac SE | In force | High confidence | ||
| US 12,194,089 | Coronavirus Vaccine In force · High confidence | Curevac SE | In force | High confidence | ||
| US 12,390,523 | Coronavirus Vaccine In force · High confidence | Curevac SE | In force | High confidence | ||
| Application 19/026,328 | Coronavirus Vaccine Abandoned Abandoned Nov 5, 2026 | CureVac SE | Abandoned | Abandoned Nov 5, 2026 | ||
| Application 19/317,057 | Coronavirus Vaccine Pending Not granted | CureVac SE | Pending | Not granted |
10 of 10 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
8 of these are in force and held by CureVac AG.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.